Accéder au contenu
Merck

MP0035

Kit de détection par PCR LookOut® pour mycoplasmes

Optimized for use with JumpStart™ Taq DNA Polymerase, D9307.

Synonyme(s) :

PCR-based mycoplasma screening

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

A propos de cet article

NACRES:
NA.75
UNSPSC Code:
12352207

Principaux documents

Voir toute la documentation
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Kit de détection par PCR LookOut® pour mycoplasmes, Optimized for use with JumpStart™ Taq DNA Polymerase, D9307.

quality

Not suitable for clinical diagnostic use. Will not detect clinically relevant species such as M. pneumoniae and U. urealyticum

packaging

pkg of 1 kit

technique(s)

PCR: suitable

application(s)

detection
microbiology

compatibility

Optimized for use with JumpStart™ Taq DNA Polymerase, D9307.

storage temp.

2-8°C

Quality Level

100

Application

Vidéo du protocole d'utilisation du kit de détection par PCR pour mycoplasmes
Le kit de détection par PCR LookOut® pour mycoplasmes a été utilisé pour le criblage d'infections à mycoplasmes.

General description

Le kit de détection par PCR LookOut® pour mycoplasmes s'appuie sur la PCR (réaction en chaîne par polymérase), qui s'est imposée comme la technique de choix pour la détection ultrasensible des contaminations par Mycoplasma, Acholeplasma et Ureaplasma dans les cultures cellulaires et d'autres échantillons biologiques dérivés de cultures cellulaires. Ce kit a été testé avec succès pour l'amplification de l'ADN génomique de Mycoplasma fermentans en concentrations de 20 000 à 20 copies.
Les tubes réactionnels fournis avec le kit sont prérevêtus des dNTP, des amorces et du colorant de charge requis. Le protocole est beaucoup plus rapide qu'avec les méthodes classiques, où les tubes réactionnels doivent être chargés un par un.

Other Notes

The kit has been optimized for use with Product No. D9307. Any DNA polymerase with a 3’-5’ exonuclease activity is NOT recommended. These include Tli, Pfu,and Pwo. Those DNA polymerases that may be used include Taq, Tfl, and Tth.

Legal Information

JumpStart is a trademark of Sigma-Aldrich Co. LLC
LookOut is a registered trademark of Merck KGaA, Darmstadt, Germany

Classe de stockage

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
BCCN6452
BCCM7998
BCCM5625
BCCL4114
BCCL4119

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. What is the difference between Product No. MP0025 (VenorGem Mycoplasma Detection Kit) and Product No. MP0035 (Lookout Mycoplasma Detection Kit)?

    The assay kits have a similar range of species detected (see product insert for listing).  For Product No. MP0025, the components are supplied as individual reagents. For Product No. MP0035, the components are supplied in reaction tubes, already mixed and ready for addition of sample and Taq. The internal control for Product No. MP0035 is at 481 bp rather than 191 bp as found in Product No. MP0025.

  3. How many tests can be performed with Product MP0035, LookOut® Mycoplasma PCR Detection Kit?

    The kit contains 8 positive control reaction tubes and 24 test reaction tubes.  A positive control and negative control should be run with each assay.  Depending upon the number of samples run with each assay, the kit could test up to 24 samples.

  4. Which species of Mycoplasma will Product MP0035, LookOut® Mycoplasma PCR Detection Kit, recognize?

    Detection of all mycoplasma species tested so far and usually encountered as contaminants in cell cultures  This kit will detect A. laidlawii, M. agalactiae, M. arginini , M. arthritidis, M. bovis, M. cloacale, M. falconis, M. faucium, M. fermentans, M. hominis, M. hyorhinis, M. hyosynoviae, M. opalescens, M. orale, M. primatum, M. pulmonis, M. salivarium, M. spermatophilum, M. timone.  This kit is not suitable for detection of M. pneumoniae, U. urealyticum, or other clinically associated species.

  5. How much DNA is necessary for use with Product MP0035, LookOut® Mycoplasma PCR Detection Kit?

    Detection of Mycoplasma sp. requires less than 5 mycoplasma genomes per microliter of sample.  This is approximately 1-5 fg of DNA.

  6. When using Product MP0035, LookOut® Mycoplasma PCR Detection Kit, there is no band for the internal control?

    When a customer observes a band with the positive control and no band for the negative control, it is possible that the Taq could be the problem. We observe a lack of sensitivity with some polymerases from other manufacturers. The activity of the polymerases was enough to amplify the positive control but not the internal amplification control. The internal amplification control is the meter for the sensitivity of the PCR and the activity of the Taq used. The positive control contains more DNA and is good for result evaluation, only. We recommend that the customer use Jump Start Taq (Product No. D9307) as indicated in the protocol.

  7. Product MP0035, LookOut® Mycoplasma PCR Detection Kit does not contain TAQ.  What DNA polymerase should be used?

    The kit has been optimized for use with Product No. D9307. Any DNA polymerase with a 3’-5’ exonuclease activity is NOT recommended. These include Tli, Pfu,and Pwo. Those DNA polymerases that may be used include Taq, Tfl, and Tth.

  8. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  9. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  10. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  11. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Dmitri Pchejetski et al.
Cancer research, 70(21), 8651-8661 (2010-10-21)
Radiotherapy is widely used as a radical treatment for prostate cancer, but curative treatments are elusive for poorly differentiated tumors where survival is just 15% at 15 years. Dose escalation improves local response rates but is limited by tolerance in
Nellie Moshkovich et al.
Cancer research, 80(11), 2125-2137 (2020-04-09)
Peptidylarginine deiminases (PADI) catalyze posttranslational modification of many target proteins and have been suggested to play a role in carcinogenesis. Citrullination of histones by PADI4 was recently implicated in regulating embryonic stem and hematopoietic progenitor cells. Here, we investigated a
Soudabeh Rad Pour et al.
Frontiers in oncology, 10, 51-51 (2020-03-03)
Dysregulation of the kynurenine pathway has been regarded as a mechanism of tumor immune escape by the enzymatic activity of indoleamine 2, 3 dioxygenase and kynurenine production. However, the immune-modulatory properties of other kynurenine metabolites such as kynurenic acid, 3-hydroxykynurenine
Lucian Romeo Farcal et al.
Nanotoxicology, 7(6), 1095-1110 (2012-07-10)
An in vitro human alveolar barrier established by the coculture of epithelial human cell line NCI-H441 with endothelial human cell line ISO-HAS1 was used to evaluate the effects of amorphous silicon dioxide nanoparticles (SiNPs), in the presence or absence of
Jennifer Mary Wymant et al.
Journal of Cancer, 11(11), 3288-3302 (2020-04-02)
Efficacious anticancer therapies for targeting plasma membrane receptors with antibody based therapeutics are often contingent on sufficient endocytic delivery of receptor and conjugate to lysosomes. This results in downregulation of receptor activity and, in the case of antibody-drug conjugates (ADCs)
Afficher tous les articles scientifiques apparentés

Contenu apparenté

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique